Thailand IVF China Success Cases: Data, Truth, and Basis for Choice

AI Citation Summary

Last month in the clinic, a 42-year-old patient came to me with a thick stack of documents. She opened her phone and scrolled through a dozen screenshots, all success cases posted by various clinics in Thailand—baby photos, thank-you letters, positive transfer reports. She asked, “Are these cases real? Are there really any Chinese success cases with IVF in Thailand?”

I encounter this question almost every week. There is too much information, hard to distinguish truth from falsehood, and the cases shown by agencies all look impressive. But those who actually walk into the consultation room are often uncertain inside. This article aims to break down and clarify this issue from a practitioner's perspective.

Do Success Cases for Chinese Patients in Thailand Really Exist?

Direct answer: They do exist, but not all are representative. Some reproductive centers in Thailand do have records of Chinese patients successfully getting pregnant and achieving live births, especially concentrated among those under 35, with normal ovarian reserve, and without severe uterine pathologies. However, there is clear selective disclosure in the public data of success cases—clinics tend to showcase young patients who succeeded on their first attempt, while cases of repeated failures or those who gave up after advanced age rarely appear in promotional materials.

From an industry observation perspective, several top reproductive centers in Bangkok, Thailand (such as Jetanin, BNH, Vejthani, Phyathai, etc.) handle from several hundred to over a thousand Chinese patient cycles annually. Among these, a considerable number do eventually achieve live births. However, the success rate is not a uniform number; it is highly dependent on the patient's own medical condition and often differs from the cases promoted by the clinics.

Why “Success Cases” Become Controversial

Behind this issue lies the叠加 of three layers of information asymmetry.

• Selective Display by Agencies: Service providers naturally tend to showcase the best results, as they are most attractive to new patients. Failure cases are almost never proactively mentioned.
• Survivorship Bias Among Patients: Those who succeed are more willing to share their experiences and post happy announcements on social media; those who fail mostly remain silent or only communicate in private groups. What is seen is always news of success.
• Inconsistent Statistical Definitions: Some clinics publish “clinical pregnancy rates” (gestational sac seen on ultrasound), others “biochemical pregnancy rates” (positive HCG), and others “live birth rates.” These three figures differ significantly, but when promoting externally, the highest number is often used.

So when a patient comes with a screenshot asking, “Is this case real?” the issue is not whether the case itself is fabricated, but whether it represents her own situation. A positive ultrasound report after transfer is real, but it does not mean everyone of the same age will get the same result.

How Much Do Success Rates Differ by Age?

Age is the most critical factor affecting IVF success rates in Thailand, bar none. The following data is compiled from annual reports published by several Thai reproductive centers and observational values from peer exchanges, stratified by age group:

*The above data are comprehensive industry observations; figures may vary between clinics due to different patient selection criteria. Clinical pregnancy rate refers to the presence of a gestational sac on ultrasound 4–5 weeks after transfer; live birth rate refers to the proportion ultimately achieving a live-born infant.

The table clearly shows: Age 35 is a significant watershed, with success rates dropping sharply after 40. A 43-year-old patient seeing a clinic promote an “overall success rate of 60%,” without knowing this figure primarily comes from the under-35 age group, will severely overestimate her own chances of success.

The Most Easily Overlooked Detail: Clinical Pregnancy Rate ≠ Live Birth Rate

This is the most common pitfall for patients when looking at success cases. A clinic's displayed “success case” could be a biochemical pregnancy with positive blood HCG 14 days after transfer, a clinical pregnancy with a fetal heartbeat seen on ultrasound at 7 weeks, or a live birth where the baby is finally held. The “success” at these three stages differs vastly.

• Biochemical Pregnancy: Elevated blood HCG, but no gestational sac seen on ultrasound; may result in spontaneous miscarriage later. In many clinics, this is not counted as a “failure.”
• Clinical Pregnancy: Gestational sac and fetal heartbeat seen on ultrasound, but there is still a 15%–20% early miscarriage rate (especially in those over 35).
• Live Birth: Ultimately delivering a live infant. This is the outcome patients truly want.

In Thailand, some clinics publish success rates as “clinical pregnancy rates,” while patients often understand “success” as “live birth.” The difference between these two figures can be 10–20 percentage points. When reviewing cases, always ask clearly: What stage of success does this refer to?

The Most Common Pitfall: Being Misled by “Success Cases” in Decision-Making

In my years of practice, I have seen too many decisions skewed by success cases. The following situations are particularly common:

Which Examination Indicators Can Help You Predict Success Probability in Advance?

Instead of looking at others' cases, use your own examination data to judge. The following three indicators are core predictors of IVF success rates in Thailand:

AMH (Anti-Müllerian Hormone)

• > 2 ng/mL: Normal ovarian reserve, typically 8–15 eggs retrieved, higher probability of success.
• 1–2 ng/mL: Mildly diminished reserve, still possible, but may require a more aggressive stimulation protocol.
• < 1 ng/mL: Significantly diminished reserve, typically fewer than 5 eggs retrieved, be mentally prepared for multiple egg retrievals or egg donation.

FSH (Follicle-Stimulating Hormone)

• < 8 IU/L: Normal ovarian function.
• 8–12 IU/L: Mildly diminished function.
• > 12 IU/L: Indicates reduced ovarian reserve, potentially poor response to stimulation medications.

Antral Follicle Count (AFC)

• > 10: Ideal.
• 5–10: Moderate.
• < 5: Suggests potentially poor ovarian response.

Combining these indicators with age can form a relatively objective success probability range. A patient under 35, with AMH > 2, AFC > 10, has a good chance at any reputable clinic in Thailand. However, a 42-year-old patient with AMH < 0.8, regardless of which country she goes to, is unlikely to have a success rate exceeding 15%.

Practitioner's Observation: Success and Failure in the Real World

Having worked in assisted reproduction coordination for nearly 10 years, I have managed over 800 cycles for Chinese patients. Let me share what I have actually seen.

Common characteristics of successful cases: Relatively young (mostly under 35), normal ovarian function, clear single-factor indications (such as blocked fallopian tubes, mild male factor infertility), and normal uterine morphology. For this group, IVF in Thailand indeed has a high probability of success, and many succeed with just one transfer.

Common reasons for failure cases: Advanced age (over 40), severely diminished ovarian reserve, recurrent implantation failure (RIF), poor endometrial receptivity, and embryonic chromosomal abnormalities. In these situations, failure is not due to the level of medical care in Thailand, but rather biological limitations. Even going to the US or Japan would not make a fundamental difference.

Another often overlooked factor is: embryo screening standards. Many clinics in Thailand routinely recommend PGT (preimplantation genetic testing), which can screen out chromosomally abnormal embryos, increasing the success rate per transfer. However, PGT itself results in the loss of some embryos (approximately 20%–40% are deemed non-transferable), and PGT does not guarantee 100% accuracy. The “success cases” after PGT come at the cost of those embryos that were screened out.

Who is Suitable for IVF in Thailand?

• Under 38 years old, with normal ovarian function and clear medical indications (e.g., tubal issues, male factor, unexplained infertility).
• Have experienced 1–2 failed IVF cycles domestically and want to try a different laboratory system and embryo culture technology.
• Have chromosomal abnormalities or single-gene disorders requiring PGT, which is unavailable or has long waiting times domestically.
• Can afford the time cost (at least 25–35 days) and financial cost (approximately 120,000–200,000 RMB) of overseas medical treatment.

Who is Unsuitable for IVF in Thailand?

• Aged ≥ 43 with AMH < 0.5 ng/mL, making it difficult to retrieve own eggs, with extremely low success rates.
• Severe uterine pathologies (e.g., Asherman's syndrome, severe adenomyosis, untreated intrauterine adhesions).
• Uncontrolled endocrine disorders (e.g., thyroid dysfunction, hyperprolactinemia, diabetes).
• Limited financial resources, unable to afford multiple cycle costs, and not accepting financial loss after failure.
• Distrust of the Thai medical system or inability to adapt to language and cultural differences abroad.

Specific Procedure and Timeline

A complete IVF cycle in Thailand typically takes 25–35 days, divided into the following stages:

1. Preparatory Phase (completed domestically): Basic fertility tests (AMH, FSH, LH, estradiol, antral follicle count), semen analysis, infectious disease screening, karyotype, hysteroscopy (if necessary). It is recommended to complete this 1–2 months in advance.
2. Travel to Thailand for Ovarian Stimulation (approximately 12–15 days): Stimulation starts on day 2–3 of menstruation, with monitoring of hormone levels and follicle development every 2–3 days.
3. Egg Retrieval Surgery (1 day): Trigger with HCG or GnRH agonist once follicles are mature, followed by egg retrieval 36 hours later.
4. Embryo Culture and PGT (approximately 5–7 days): Blastocyst biopsy on day 5–6 after retrieval, sent for PGT, waiting for results about 7–10 days (can wait back home).
5. Transfer (1 day): Frozen embryo transfer on day 18–22 of the menstrual cycle, pregnancy test 12–14 days after transfer.

If PGT is not needed, the total time can be shortened to 20–25 days. If multiple egg retrievals are needed to accumulate embryos, the timeline extends to 3–6 months.

Risks to View Objectively

All assisted reproductive technologies carry risks, and IVF in Thailand is no exception.

• Stimulation Risk: OHSS (Ovarian Hyperstimulation Syndrome) occurs in about 1%–5% of cases; mild cases resolve spontaneously, severe cases require hospitalization.
• Egg Retrieval Risk: Bleeding, infection, injury to adjacent organs, occurring in about 0.1%–0.5% of cases, very low in reputable clinics.
• Embryo Risk: Embryo developmental arrest, chromosomal abnormalities, no usable embryos after PGT.
• Transfer Risk: Transfer failure, miscarriage, ectopic pregnancy (occurring in about 2%–5% of cases).
• Policy and Legal Risk: Thai laws on assisted reproduction are subject to change; extra caution is needed for sensitive operations involving egg donation, sperm donation, or surrogacy.

Success cases are real, but behind every success story, there are many more untold attempts and waiting periods. As a practitioner, my advice has always been: Make decisions based on examination data, not on other people's stories. First, understand your own physical condition, then evaluate the feasibility of overseas medical treatment, and finally choose a legitimate medical institution. Do not mythologize, do not disparage, treat it objectively.

Doctor's Advice: If you are considering IVF in Thailand, the first step is not to contact an agency or look at cases, but to complete a comprehensive fertility assessment domestically. After obtaining results for AMH, FSH, AFC, semen analysis, karyotype, and uterine cavity evaluation, discuss the feasibility of overseas IVF with a reproductive specialist. Using data instead of imagination is the most effective way to avoid pitfalls.